Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy. [electronic resource] by
- de Jong, M
- Breeman, W A
- Bernard, B F
- Bakker, W H
- Schaar, M
- van Gameren, A
- Bugaj, J E
- Erion, J
- Schmidt, M
- Srinivasan, A
- Krenning, E P
Producer: 20010524
In:
International journal of cancer vol. 92
Availability: No items available.
|
|
6.
|
Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount. [electronic resource] by
- de Jong, M
- Breeman, W A
- Bernard, B F
- van Gameren, A
- de Bruin, E
- Bakker, W H
- van der Pluijm, M E
- Visser, T J
- Mäcke, H R
- Krenning, E P
Producer: 19990916
In:
European journal of nuclear medicine vol. 26
Availability: No items available.
|
|
7.
|
Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides. [electronic resource] by
- Breeman, Wouter A P
- Fröberg, A C
- de Blois, E
- van Gameren, A
- Melis, M
- de Jong, M
- Maina, T
- Nock, B A
- Erion, J L
- Mäcke, H R
- Krenning, E P
Producer: 20090310
In:
Nuclear medicine and biology vol. 35
Availability: No items available.
|